We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Calcium Carbonate Nanoparticles Stop Cancer by Neutralizing the Tumor Microenvironment

By LabMedica International staff writers
Posted on 17 Feb 2016
Print article
Image: Space-filling model of part of the crystal structure of calcium carbonate, CaCO3 (Photo courtesy of Wikimedia Commons).
Image: Space-filling model of part of the crystal structure of calcium carbonate, CaCO3 (Photo courtesy of Wikimedia Commons).
Tumor growth was halted in a mouse cancer model by the injection of novel calcium carbonate nanoparticles that neutralized the pH of the tumor microenvironment.

The acidic extracellular environment of tumors increases their aggressiveness and potential to metastasize, but few methods exist to selectively modulate the extracellular pH of the tumor environment. Transient flushing of biological systems with alkaline fluids or proton pump inhibitors is impractical and nonselective.

Investigators at Washington University (St. Louis, MO, USA) tried a new approach to modulate the pH of the tumor microenvironment. They used two processes, polyethyleneglycol-based diffusion and ethanol-assisted diffusion, to prepare calcium carbonate nanoparticles ranging in size from 20 to 300 microns. The nanoparticles were suspended in an albumin-based solvent that prevented aggregation and allowed them to be injected intravenously into an animal.

The investigators reported in the December 25, 2015, online edition of the journal Nanoscale that by using a mouse cancer model they were able to demonstrate that the selective accumulation of nano-calcium carbonate in tumors increased tumor pH over time, eventually reaching pH 7.4. Daily injections of calcium carbonate nanoparticles halted tumor growth in the mouse fibrosarcoma model, but stopping the injections allowed tumor growth to resume.

"Cancer kills because of metastasis," said Avik Som, a medical and doctoral student in biomedical engineering at Washington University. "The pH of a tumor has been heavily correlated with metastasis. For a cancer cell to get out of the extracellular matrix, or the cells around it, one of the methods it uses is a decreased pH. Calcium and carbonate are both found heavily in the body, and they are generally non-toxic. When calcium carbonate dissolves, the carbonate becomes carbon dioxide and is released through the lungs, and calcium is often incorporated into the bones."

Related Links:

Washington University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.